CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹20,425 Cr | ₹19,483 Cr | ₹17,763 Cr | ₹17,251 Cr | ₹14,911 Cr |
What is the latest Total Expenditure of CIPLA ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹20,425 Cr |
| Mar2025 | ₹19,483 Cr |
| Mar2024 | ₹17,763 Cr |
| Mar2023 | ₹17,251 Cr |
| Mar2022 | ₹14,911 Cr |
How is Total Expenditure of CIPLA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹20,425 Cr | 4.83 | |
| Mar2025 | ₹19,483 Cr | 9.68 | |
| Mar2024 | ₹17,763 Cr | 2.96 | |
| Mar2023 | ₹17,251 Cr | 15.70 | |
| Mar2022 | ₹14,911 Cr | - | |
Compare Total Expenditure of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹112,910.2 Cr | -0.1% | 4.8% | -6.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,926.0 Cr | -1.2% | -2.3% | 5.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,062.0 Cr | -1% | -0.9% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,806.0 Cr | -1.3% | 1.4% | 38.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,755.0 Cr | -2.8% | -0.3% | 1.2% | Stock Analytics | |
| MANKIND PHARMA | ₹97,215.3 Cr | -1% | 1.5% | -3.8% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.1% |
4.8% |
-6.9% |
| SENSEX | -2% |
-3.8% |
-8.6% |
You may also like the below Video Courses